Platinum-Based Drugs in Cancer Therapy - Comprehensive Oncology Text

In this review of Platinum-Based Drugs in Cancer Therapy, the bottom line is clear: this is an advanced, interdisciplinary survey best suited to oncology researchers and clinicians who need a focused, mechanistic treatment of platinum anticancer agents. The book compiles contributions from international experts and offers the most useful single-volume discussion of platinum drug chemistry, DNA interactions, transport into tumor cells, and emergent agents, making it a valuable reference rather than a basic textbook for students.

Key Features

• Comprehensive coverage: Reviews chemistry, molecular mechanisms, and clinical use of platinum drugs in one focused volume for rapid reference.
• Expert contributors: Leading international specialists provide authoritative perspectives across chemistry, biology, and clinical oncology.
• Molecular detail: Examines platinum drug interactions with DNA, including mismatch repair and replicative bypass, to clarify mechanism-based resistance and response.
• Transport and apoptosis: Discusses the transport of platinum agents into tumor cells and the role of apoptosis in therapeutic outcomes, informing translational research.
• Future agents considered: Evaluates emergent platinum drugs such as orally active compounds, ZD0473, and the polynuclear BBR3464 to outline future therapeutic prospects.

Who It's For

The primary audience is oncology specialists, medicinal chemists, and cancer therapeutics researchers who need an in-depth, mechanistic review of platinum anticancer agents and their clinical applications. It is particularly useful for clinicians and investigators working on drug resistance, DNA repair pathways, and novel platinum compounds.

Those seeking an introductory textbook or a clinical guide to general cancer care should look elsewhere; the book assumes familiarity with molecular biology and inorganic chemistry and is written as a specialist reference rather than a primer for nonexperts.

Pros & Cons

Pros

• Authoritative interdisciplinary chapters that synthesize chemistry and clinical perspectives for holistic understanding.
• Detailed discussion of DNA interactions and cellular transport mechanisms that informs research into resistance and therapeutic improvement.
• Coverage of emergent compounds like ZD0473 and BBR3464 gives readers insight into future drug development directions.

Cons

• The material is specialist and dense, which limits accessibility for readers without a strong background in molecular oncology or chemistry.

Specifications

Title	Platinum-Based Drugs in Cancer Therapy
Series	Cancer Drug Discovery and Development
Authors / Editors	Lloyd R. Kelland, Nicholas P. Farrell
Scope	Chemistry, molecular interactions, transport, apoptosis, and future agents
Focus	Platinum anticancer drugs and therapeutic prospects
Audience	Oncology researchers, medicinal chemists, cancer therapeutics specialists

Our Verdict

Platinum-Based Drugs in Cancer Therapy is a strong, specialist reference that pulls together chemistry, cellular biology, and clinical perspectives on platinum agents. Researchers and clinicians focused on mechanism, resistance, and novel platinum compounds will find it excellent value; readers seeking an introductory or broad clinical text should consider a different title.

Frequently Asked Questions

Does this book cover new platinum compounds?
Yes. The text specifically discusses emergent agents including orally active compounds, ZD0473, and the polynuclear BBR3464.

Is the book suitable for general clinical practice?
The volume is specialist in tone and best suited to researchers and oncology clinicians rather than general practitioners seeking a broad clinical manual.

Does it address mechanisms of resistance?
Yes. It examines DNA mismatch repair, replicative bypass, and transport mechanisms that underpin resistance and response to platinum drugs.